Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZX90
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,326
Award facts
- Contract value 100% obligated
- $33,326.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,326.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The contract is a firm fixed-price delivery order with an ultimate completion date of October 2, 2025, and was awarded on September 11, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The order will be fulfilled at the company's Park Ridge location and represents a continuation of the company's role as a critical supplier within the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. Under this SPE2DB program vehicle, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables supporting Department of Defense healthcare facilities worldwide. Nexplanon, a subdermal contraceptive implant, represents one category within the company's extensive federal pharmaceutical portfolio, which has historically included oncology treatments, vaccines, and specialty medications. DMS Pharmaceutical Group's established position as a preferred vendor demonstrates its consistent capability to deliver critical medical supplies to military health systems.
Quick answers
Who was awarded contract SPE2DB25FZX90?
SPE2DB25FZX90 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FZX90 worth?
The government has obligated $33,326 on SPE2DB25FZX90.
Is contract SPE2DB25FZX90 an order under another contract?
Yes. SPE2DB25FZX90 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX90 competed?
The extent of competition for SPE2DB25FZX90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award